Innovaccer’s data and analytics platform and suite of population health management solutions delivers better financial, clinical, operational, and experiential outcomes
SAN FRANCISCO—December 05, 2023—Today, Innovaccer Inc. the data platform that accelerates innovation, announced that it has been named a Leader in the recent IDC MarketScape: U.S. Value-Based Health Analytics 2023 Vendor Assessment (DocDocument number:# US51244923, October 2023). Innovaccer believes that this recognition is based on its platform’s analytics capabilities to develop interoperable applications that help providers and payers improve patient engagement, risk stratification, care management and operational performance.
Innovaccer is known for its advanced value-based analytical capabilities including Data Activation Platform (DAP), Patient 360, population health analytics suite, and its risk stratification and predictive models. As per Innovaccer’s clients, its capabilities and menu of services align with the needs of the market and health systems.
“We believe that the report highlights Innovaccer's ability to support various risk stratification models, which provide valuable insights for customers to enhance reimbursement opportunities and target personalized interventions for members with high or rising risks,” noted Sandeep Gupta, co-founder and COO. “In addition to Innovaccer's proprietary risk stratification models, the platform also supports other proprietary and predictive risk models, such as disease progression, future cost liability, and readmissions, tailored to meet the specific needs of their member population and population health management goals,” he added.
Innovaccer unifies patient data, improving care quality and reducing costs. The following Innovaccer solutions, accelerate healthcare innovation for organizations:
“We are incredibly honored to be recognized as a Leader in U.S. value-based health analytics by the IDC MarketScape,” said Abhinav Shashank co founder and CEO of Innovaccer. ”This acknowledgment is a testament to the hard work and dedication we put towards the current state of healthcare, while also working to usher in a better future for healthcare by empowering organizations with data-driven insights. By integrating healthcare data, we are advancing value-based healthcare outcomes with innovative solutions that make a difference in the lives of patients and the industry as a whole.”
About IDC MarketScape
IDC MarketScape vendor assessment model is designed to provide an overview of the competitive fitness of ICT (information and communications technology) suppliers in a given market. The research methodology utilizes a rigorous scoring methodology based on both qualitative and quantitative criteria that results in a single graphical illustration of each vendor’s position within a given market. IDC MarketScape provides a clear framework in which the product and service offerings, capabilities and strategies, and current and future market success factors of IT and telecommunications vendors can be meaningfully compared. The framework also provides technology buyers with a 360-degree assessment of the strengths and weaknesses of current and prospective vendors.
Innovaccer Inc. is the data platform that accelerates innovation. The Innovaccer platform unifies patient data across systems and care settings and empowers healthcare organizations with scalable, modern applications that improve clinical, financial, operational, and experiential outcomes. Innovaccer’s EHR-agnostic solutions have been deployed across more than 1,600 hospitals and clinics in the US, enabling care delivery transformation for more than 96,000 clinicians, and helping providers work collaboratively with payers and life sciences companies. Innovaccer has helped its customers unify health records for more than 54 million people and generate over $1.5 billion in cumulative cost savings. The Innovaccer platform is the #1 rated Best-in-KLAS data and analytics platform by KLAS, and the #1 rated population health technology platform by Black Book. For more information, please visit innovaccer.com.